Tekla Life Sciences Investors
Tekla Life Sciences Investors
Location
Massachusetts
Founded
2000-01-26
Website
https://www.teklacap.com
Articles
78 Articles
Category
Management Investment Offices, Open-End
Description
Tekla Life Sciences Investors (HQL) is a non-diversified closed-end healthcare fund that primarily invests in the life sciences industry. The fund aims to provide long-term capital appreciation through investments in companies in the life sciences industry with potential for above-average long-term growth. It focuses on smaller, emerging companies and may invest up to 40% of its assets in restricted securities of both public and private companies. The fund is traded on the New York Stock Exchange under the ticker HQL.
Filters
Stock Market (16)
General Investment (6)
Tax Havens (6)
Stock Research & Ratings (5)
Acquisition (4)
Business Model Resilience (4)
Shareholders Feedback (4)
Share Repurchase (4)
Divestment (3)
Deals & Tenders (2)
Issuing Shares (2)
Regulations (2)
Collaboration (2)
Business Restructuring (2)
Corporate Governance (2)
Financial Update/Profit Warning (1)
Supply Chain Management (1)
Competitive Behaviour (1)
Going Public (1)
Investment Requests (1)
Investors (1)
Business Development (1)
Articles
2023-09-29 (tmcnet.com)
Tekla Life Sciences Investors Paid Distribution
Tekla Life Sciences Investors Paid Distribution
Read more